|
|
Volumn 14, Issue 8, 2008, Pages 1159-1166
|
|
Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis
|
|
Author keywords
Colorectal cancer; Cytoreductive surgery; Gastric cancer; Intraperitoneal hyperthermic chemotherapy; Ovarian cancer; Peritoneal carcinomatosis; Peritoneal mesothelioma
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
GEMCITABINE;
MITOMYCIN C;
MITOXANTRONE;
OXALIPLATIN;
ABSCESS;
BILE LEAKAGE;
BONE MARROW SUPPRESSION;
BRAIN INFARCTION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER STAGING;
CLINICAL TRIAL;
COLORECTAL CANCER;
COMPUTER ASSISTED TOMOGRAPHY;
CYTOREDUCTIVE SURGERY;
CYTOTOXICITY;
DEEP VEIN THROMBOSIS;
DRUG PENETRATION;
DRUG TREATMENT FAILURE;
ENDOMETRIUM CANCER;
HEART FAILURE;
HUMAN;
HYPERTHERMIC THERAPY;
ILEUS;
INTESTINE FISTULA;
INTESTINE PERFORATION;
KIDNEY FAILURE;
LAPAROSCOPY;
LUNG EMBOLISM;
LUNG INSUFFICIENCY;
MESOTHELIOMA;
MORBIDITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OPERATION DURATION;
OPTIMAL DRUG DOSE;
OVARY CANCER;
PANCREATITIS;
PATHOLOGICAL ANATOMY;
PATIENT SELECTION;
PERITONEUM CANCER;
PERITONEUM METASTASIS;
PERITONEUM PSEUDOMYXOMA;
PEROPERATIVE CARE;
PNEUMONIA;
POSITRON EMISSION TOMOGRAPHY;
POSTOPERATIVE PERIOD;
PREOPERATIVE EVALUATION;
RECURRENT CANCER;
REVIEW;
STAPHYLOCOCCUS INFECTION;
STOMACH CANCER;
STOMACH PERFORATION;
SURGICAL TECHNIQUE;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
|
|
EID: 40549123018
PISSN: 10079327
EISSN: None
Source Type: Journal
DOI: 10.3748/wjg.14.1159 Document Type: Review |
|
Times cited : (83)
|
|
References (104)
|
